source
- Alphabet’s Isomorphic Labs draws VC interest as it seeks to turn AI protein modeling into drug discovery engineIsomorphic Labs, an Alphabet spin‑off, is building a platform that uses its protein‑modeling AI to create new medicines. The secretive startup has not been actively raising money, but venture firm…
- Enlivex cuts 60% of staff, halts preclinical R&D and slashes exec salaries to fund osteoarthritis trialEnlivex, an Israeli biotech developing a cell‑based immunotherapy called allocetra for knee osteoarthritis, announced today that it is reducing its workforce by 60 percent. The cut reduces the sta…